Back to companies

Top 10 Private Equity Investors in Medical Industry in the World in 2021 by Deal Volume

Casdin Capital LLC, Hellman & Friedman LLC, First Light Asset Management, LLC, Orbimed Advisors LLC, and Perceptive Advisors LLC are among the top 5 private equity investors in the medical industry in 2021 by deal volume. In terms of the geographic split, 8 out of the world’s top 10 private equity investors in the medical industry are headquartered in North America, whereas the remaining 2 are based in Europe. They employed a total of 1,471 people in 2021. The Samlyn Capital-Satsuma Pharmaceuticals deal was one of the major deals in the medical sector in 2021. SVB Securities LLC served as exclusive financial advisor to Satsuma Pharmaceuticals Inc. Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel therapeutic product candidate for the acute treatment of migraine, has announced that it has agreed to sell 14,084,507 shares of its common stock to certain institutional investors in private investment in public equity (PIPE) financing at an offering price of $5.68 per share, to raise gross proceeds of $80 million. The deal was completed in Q1 2021. The TPG-Caris Life Sciences deal was another major deal in the medical sector in 2021. Shearman & Sterling LLP served as legal advisors to Caris Life Sciences Inc. Caris Life Sciences, an innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity round at a post-money valuation of $7.83 billion. The deal was completed in Q2 2021. The EQT-Lifebrain deal was another major deal in the medical sector in 2021. Ernst & Young Global Ltd served as financial advisor to EQT, while Orrick, Herrington, and Sutcliffe LLP served as legal advisor to EQT. EQT Partners AB, a private equity firm, has agreed to acquire Lifebrain, a company engaged in laboratory medicine for patients, from Investindustrial, a private equity firm, for a purchase consideration of EUR1 billion. The deal was completed in Q4 2021.

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

You've reached the maximum number of page views, to continue viewing please Sign Up for a free account below

Already have an account? Sign In

Get unlimited* access to trusted data with a free account, including:

  • 8000+ company profiles
  • 10000+ data & insights
  • Free reports
  • Ability to save searches
  • Free demos of our platforms

Every month we will be sharing datasets which will help you make smarter and faster decisions.

*Registering for a free account gives you unlimited access to our partially available premium datasets to demonstrate the power of our subscribed platforms. You will have access to the entire universe of content when you buy one of our premium products.

 

First name is required
Last name is required
Job Title is required
Company is required
Work email is required
Country is required
Industry is required
 Tick here to opt-out of curated industry news, reports, and event updates from GlobalData
By clicking 'Submit' you agree to our Terms & Conditions and consent to us collecting your details for the purposes of your enquiry.
 

GDPR + CCPA Compliant

Personal & transactional information is kept safe from unauthorized use.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.